SPC70

Aflibercept

  • Status:
    Afskrifuð
  • Application date:
    16.5.2013
  • Application published:
    15.6.2013
  • Grant published:
    15.5.2020
  • Max expiry date:
    4.2.2028
  • Medicine name:
    Zaltrap
  • Medicine for children:
    No

Timeline

Today
16.5.2013Application
15.6.2013Publication
15.5.2020Registration
4.2.2028Expires

Marketing license

  • IS authorization number:
    EU/1/12/814/001-003
  • Date:
    12.2.2013
  • Foreign authorization number:
    EU/1/12/814
  • Date:
    1.2.2013

Owner

  • Name:
    Aventis Pharma S.A.
  • Address:
    20, avenue Raymond Aron, Antony FR

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents